Novacta secures funding to further develop antibiotics

07/9/2009 | Business Weekly (U.K.)

Novacta Biosystems secured more than $21 million in a financing round led by Celtic Pharma's second fund. The company will use the funding to advance the development of its line of hospital superbug-focused antibiotics, called "lantibiotics." Drugs being developed include treatments for Clostridium difficile and methicillin-resistant Staphylococcus aureus.

View Full Article in:

Business Weekly (U.K.)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Financial Officer
B. E. Smith
Miramar, FL
Director of ASO Department
Bluegrass Family Health
Lexington-or could be in Nashville, TN, KY
Claims Director
Springfield, OR
Mgr NGS Provider Enrollment (I)
National Government Services - WellPoint
Harrisburg, PA
NGS Provider Enrollment Rep
National Government Services - WellPoint
Harrisburg, PA